Suki, a company specializing in voice-assistive AI and medical scribe tools, has successfully raised $70 million in funding to expand its AI assistant technology for healthcare professionals.
Suki, founded in 2017, has experienced rapid growth and established partnerships with various health systems, health tech firms, and electronic health record (EHR) solutions.
The recent funding will support an expanded partnership with MedStar Health, allowing Suki's flagship solution, Suki Assistant, to be used by thousands of MedStar Health clinicians across various specialties.
Suki Assistant leverages AI and voice technologies to alleviate the administrative burden on clinicians, improving documentation efficiency and clinician well-being. The solution has achieved a 70% adoption rate among clinicians and aims to make healthcare technology seamlessly integrated and assistive.
Suki has also formed strategic partnerships with Amwell's Converge telehealth platform and Premier, a healthcare improvement organization.
The recent funding round, led by Hedosophia and supported by Venrock and other existing investors, brings Suki's total funding to $165 million. The company plans to use the funding for new product development and expanding the capabilities of Suki Assistant. Suki's impressive financial growth is reflected in its revenue doubling in 2023 and projected to quadruple in 2024.
The AI medical assistant sector is growing rapidly, driven by the demand for technology solutions that address clinician burnout and enhance operational efficiency. Suki's innovative approach to integrating AI into healthcare workflows has garnered attention from various stakeholders, positioning the company as a leading player in the AI healthcare landscape.
Suki's technology has been integrated into more than a dozen health systems, reflecting the growing acceptance and demand for AI solutions in healthcare.